Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Bisphosphonates and osteoporosis.

× No keyword cloud information.

12 in total

Review 1. Long-term safety of bisphosphonate therapy for osteoporosis: a review of the evidence.

Authors: Uri A Liberman
Journal: Drugs Aging Date: 2006 Impact factor: 3.923

2. Radiographic features of bisphosphonate therapy in pediatric patients.

Authors: Leslie E Grissom; H Theodore Harcke
Journal: Pediatr Radiol Date: 2003-02-15

3. Atrial fibrillation and stroke associated with intravenous bisphosphonate therapy in older patients with cancer.

Authors: Gregg S Wilkinson; Jacques Baillargeon; Yong-Fang Kuo; Jean L Freeman; James S Goodwin
Journal: J Clin Oncol Date: 2010-10-12 Impact factor: 44.544

4. Osteonecrosis of the jaw induced by orally administered bisphosphonates: incidence, clinical features, predisposing factors and treatment outcome.

Authors: N Yarom; R Yahalom; Y Shoshani; W Hamed; E Regev; S Elad
Journal: Osteoporos Int Date: 2007-06-28 Impact factor: 4.507

5. Long-term reaction to bone cement in osteoporotic bone: new bone formation in vertebral bodies after vertebroplasty.

Authors: Volker Braunstein; Christoph M Sprecher; Armando Gisep; Lorin Benneker; Kathrin Yen; Erich Schneider; Paul Heini; Stefan Milz
Journal: J Anat Date: 2008-04-10 Impact factor: 2.610

Review 6. Clodronic acid formulations available in Europe and their use in osteoporosis: a review.

Authors: Bruno Frediani; Luca Cavalieri; Giovanni Cremonesi
Journal: Clin Drug Investig Date: 2009 Impact factor: 2.859

7. Safety profile of raloxifene as used in general practice in England: results of a prescription-event monitoring study.

Authors: Deborah Layton; Andrea Clarke; Lynda V Wilton; Saad A W Shakir
Journal: Osteoporos Int Date: 2004-08-07 Impact factor: 4.507

8. Pharmacokinetic considerations in determining the terminal elimination half-lives of bisphosphonates.

Authors: Kenneth C Lasseter; Arturo G Porras; Andrew Denker; Anu Santhanagopal; Anastasia Daifotis
Journal: Clin Drug Investig Date: 2005 Impact factor: 2.859

Review 9. Clinical utility of clodronate in the prevention and management of osteoporosis in patients intolerant of oral bisphosphonates.

Authors: Maurizio Muratore; Eugenio Quarta; Antonella Grimaldi; Fabio Calcagnile; Laura Quarta
Journal: Drug Des Devel Ther Date: 2011-10-19 Impact factor: 4.162

Review 10. Polytherapy and drug interactions in elderly.

Authors: Hima Bindu Gujjarlamudi
Journal: J Midlife Health Date: 2016 Jul-Sep